Document is current
Any future updates will be listed below
-
Authors
Bolek, Hatice
Sertesen Camoz, Elif
Kuzu, Omer Faruk
Karakas, Hilal
Sim, Saadet
Sekmek, Serhat
Isık, Selver
Günaltılı, Murat
Akkus, Aysun Fatma
Güzel, Halil Göksel
Tural, Deniz
Arslan, Cagatay
Goksu, Sema Sezin
Sever, Ozlem Nuray
Karadurmus, Nuri
Karacin, Cengiz
Özgüroğlu, Mustafa
Sendur, Mehmet Ali Nahit
Yekedüz, Emre
Urun, Yuksel https://orcid.org/0000-0002-9152-9887
- License Information
-
More Information
Article History
Received: 25 March 2025
Accepted: 6 January 2026
First Online: 17 January 2026
Declarations
:
: Yüksel Ürün: Advisory work —Abdi-İbrahim, Astellas, AstraZeneca, Bristol Myers-Squibb, Deva, Eczacıbaşı, Gen ilaç, Gilead, GSK, Janssen, Merck, MSD, Novartis, Pfizer, Roche; travel, honoraria and consultation fees—Abdi-İbrahim, Astellas, Bristol Myers-Squibb, Deva, Eczacıbaşı, Gen ilaç, Gilead, GSK, Janssen, Merck, Novartis, Pfizer, Roche-. All remaining authors have declared no conflicts of interest.
: This retrospective study was conducted in accordance with the Declaration of Helsinki and was approved by the Ankara University Medical Faculty Ethics Committee (Approval Number: I09-701-24). Due to the retrospective design of the study, informed consent to participate was waived by the Ankara University Medical Faculty Ethics Committee.
